BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36248341)

  • 21. Systematic Analysis of Expression Profiles and Prognostic Significance for
    Gan J; Li Y; Meng Q
    Front Mol Biosci; 2020; 7():572406. PubMed ID: 33363204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.
    Zheng X; Wang X; He Y; Ge H
    Front Mol Biosci; 2022; 9():844618. PubMed ID: 35923467
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of an immune prognostic 11-gene signature for lung adenocarcinoma.
    Yang T; Hao L; Cui R; Liu H; Chen J; An J; Qi S; Li Z
    PeerJ; 2021; 9():e10749. PubMed ID: 33552736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer.
    Wang J; Yang Q; Tang M; Liu W
    Front Oncol; 2022; 12():911316. PubMed ID: 35957916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
    Zhang T; Wang Y; Chen Y; Jin S; Gao Y; Zhang D; Wu Y
    Front Oncol; 2021; 11():669684. PubMed ID: 34497755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cytoskeleton-related gene, uso1, is required for intracellular protein transport in Saccharomyces cerevisiae.
    Nakajima H; Hirata A; Ogawa Y; Yonehara T; Yoda K; Yamasaki M
    J Cell Biol; 1991 Apr; 113(2):245-60. PubMed ID: 2010462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
    Li Q; Ma W; Chen S; Tian EC; Wei S; Fan RR; Wang T; Zhou C; Li T
    Transl Lung Cancer Res; 2020 Aug; 9(4):1361-1378. PubMed ID: 32953510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic landscape and prognosis of patients with
    Fan Z; Zhang Q; Feng L; Wang L; Zhou X; Han J; Li D; Liu J; Zhang X; Zuo J; Zou X; Cai Y; Sun Y; Wang Y
    Ann Transl Med; 2022 Feb; 10(4):188. PubMed ID: 35280362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.
    Deng Y; Chen X; Huang C; Song J; Feng S; Chen X; Zhou R
    J Oncol; 2022; 2022():3794021. PubMed ID: 35444699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance.
    Zhang L; Xu H; Ma C; Zhang J; Zhao Y; Yang X; Wang S; Li D
    J Cancer; 2020; 11(10):2962-2971. PubMed ID: 32226511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of m
    Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
    Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
    Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
    Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
    Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Prospective Biomarkers for Non-small Cell Lung Cancer: Mini-Chromosome Maintenance Proteins.
    Huang C; Lei C; Pan B; Fang S; Chen Y; Cao W; Liu L
    Front Genet; 2021; 12():587017. PubMed ID: 33936158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer.
    Chen J; Shao J; Shen A; Zhu X; Zhang X; Sun H; Wei S; Ling Y
    J Thorac Dis; 2021 Mar; 13(3):1769-1784. PubMed ID: 33841967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z; Shi R; Yuan K; Wang Y
    Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.